November 2008 - Page 56 of 76

MondayNov 03, 2008 5:17 am

Rex Energy Corporation (NASDAQ: REXX)

Rex Energy Corporation (NASDAQ: REXX), an independent energy company, is focused on acquiring, producing, exploring and developing oil and gas, with properties concentrated in the Appalachian, Illinois and Permian regions. The company strategically exploits its sizeable inventory of lower risk developmental drilling locations, while pursuing higher potential exploration drilling prospects. The company believes its success is the result of its seasoned and diversified management team. For further information, visit the Company's web site at www.rexenergycorp.com.

MondayNov 03, 2008 5:16 am

Resverlogix Corp. (TSX: RVX CN)

Resverlogix Corp. (TSX: RVX CN), a leading biotechnology company, is committed to developing innovative therapies designed to address the unmet needs of important global medical markets. The company’s NexVas™ program is mainly focused on developing novel small molecules that enhance ApoA-I. Resverlogix’s second focus is on relieving the dreadful burden of atherosclerosis and other important diseases such as acute coronary syndrome, diabetes, Alzheimer’s disease and other vascular disorders. For further information, visit the Company's web site at www.resverlogix.com.

MondayNov 03, 2008 5:16 am

China Energy Recovery (OTC BB: CGYV)

China Energy Recovery (OTC BB: CGYV), an international leader in designing, fabricating, implementing and servicing energy recovery systems, utilizes industrial waste energy to create low-cost electrical power. The company's industrial waste recycling systems are effective at reducing sulfur dioxide emissions, and allow industrial manufacturers to reduce their energy costs, decrease their emissions footprint, and generate sellable emissions credits. For further information, visit the Company's web site at www.chinaenergyrecovery.com.

MondayNov 03, 2008 5:16 am

Result Energy Inc. (TSX: RTE CN)

Result Energy Inc. (TSX: RTE CN), a junior oil & gas exploration and production company, is focused on expanding operations through a combination of internally developed prospects and strategic acquisitions. The company has interests in producing oil & gas wells in 4 separate areas, primarily in northern Alberta and west-central Saskatchewan. James Reimer, Executive Vice-President, brings more than 25 years of experience to the company and is renowned as a top industry expert regarding Paleozoic hydrothermal play systems. For further information, visit the Company's web site at www.resultenergy.com.

MondayNov 03, 2008 5:15 am

Response Genetics, Inc. (NASDAQ: RGDX)

Response Genetics, Inc. (NASDAQ: RGDX) has focused their efforts on the research and development of pharmacogenomic cancer diagnostic tests based on its patented technologies. These technologies allow the extraction and analysis of genetic information from genes derived from tumor samples stored as formalin-fixed and paraffin-embedded specimens. RGI generates revenues through diagnostic testing services and the sales of its proprietary analytical pharmacogenomic testing services of clinical trial specimens. For further information, visit the Company's web site at www.responsegenetics.com.

MondayNov 03, 2008 5:14 am

Response Biomedical Corporation (TSX: RBM CN)

Response Biomedical Corporation (TSX: RBM CN) is focused on developing, manufacturing, and marketing rapid on-site diagnostic tests designed to be used with its RAMP(R) Platform for clinical and environmental applications. The company’s novel platform represents a new paradigm in diagnostics that advantageously provides high sensitivity and dependable information in moments. The RAMP system potentially could be applied to over 250 medical and non-medical tests currently performed in laboratories. For further information, visit the Company's web site at www.responsebio.com.

MondayNov 03, 2008 5:14 am

Repros Therapeutics, Inc. (NASDAQ: RPRX)

Repros Therapeutics, Inc. (NASDAQ: RPRX) is focused on developing oral small molecule drugs to treat substantial, but unmet medical needs. The company has a proven track-record of rapidly progressing their therapeutic candidates through clinical development with efficiency. Proellex, the company’s lead drug, selectively blocks the progesterone receptor and may treat uterine fibroids, endometriosis and anemia associated with uterine fibroids. For further information, visit the Company's web site at www.reprosrx.com.

MondayNov 03, 2008 5:14 am

China Education Resources Inc. (TSX: CHN CN)

China Education Resources Inc. (TSX: CHN CN), a leading provider of products and services to China's kindergarten to grade 12 market, is focused on building the most robust and flexible educational portal in the world, capable of handling the online teaching, learning, and administrative requirements of 600,000 schools, 12 million teachers and 230 million students in China. For further information, visit the Company's web site at www.chinaeducationresources.com.

MondayNov 03, 2008 5:13 am

Repligen Corporation (NASDAQ: RGEN)

Repligen Corporation (NASDAQ: RGEN) has focused their efforts on the development of innovative therapeutics for neurological disorders. The company’s current clinical development programs are being conducted in the areas of pancreatic MRI imaging, bipolar disorder, Friedreich's ataxia and Huntington's disease. Repligen generates profits from its recombinant Protein A and has a secured source of revenue via its licensing of CTLA4-Ig. The company also receives royalties from Bristol-Myers Squibb. For further information, visit the Company's web site at www.repligen.com.

MondayNov 03, 2008 5:13 am

Remedent, Inc. (OTC BB: REMI)

Remedent, Inc. (OTC BB: REMI) is a Belgium company that strives to be a world leader in the research and development, manufacturing and marketing of oral care and cosmetic dentistry products. Remedent currently has two divisions: One that serves dental care and the other that caters to over-the-counter consumer market. With a vast array of products that are sold exclusively thru pharmacies and drug stores, Remedent is a company to keep an eye on. For further information, visit the company website at: www.remedent.com.

Site Search

Company Search

Month: November 2008

Rex Energy Corporation (NASDAQ: REXX)

Resverlogix Corp. (TSX: RVX CN)

China Energy Recovery (OTC BB: CGYV)

Result Energy Inc. (TSX: RTE CN)

Response Genetics, Inc. (NASDAQ: RGDX)

Response Biomedical Corporation (TSX: RBM CN)

Repros Therapeutics, Inc. (NASDAQ: RPRX)

China Education Resources Inc. (TSX: CHN CN)

Repligen Corporation (NASDAQ: RGEN)

Remedent, Inc. (OTC BB: REMI)

Market Basics

Newsletter Publishers

Public Companies